“Quantified Social Perception Circuit Activity as a Neurobiological Marker of Autism Spectrum Disorder,”
Researchers analyzed a series of 164 images from each of 114 individuals and discovered the brain scans of the social perception circuits indicated ASD only in boys.
This new research has the potential to improve treatment for ASD by measuring changes in the social perception brain circuit in response to different treatments. The researchers found the brain scan data can be an effective indicator of function of the circuit in males, both younger children and older patients alike.
The research is particularly relevant for ASD patients who are difficult to diagnose and treat by providing a more definitive diagnosis and in developing a treatment program when it is not clear whether behavioral, drug or a combination of those treatments would be most effective.
"The behavioral symptoms of ASD are so complex and varied it is difficult to determine whether a new treatment is effective, especially within a realistic time frame," said Malin Björnsdotter, assistant professor at the University of Gothenburg and lead author of the paper. "Brain function markers may provide the specific and objective measures required to bridge this gap."
Widespread use of brain scans?
In addition to helping to identify the most effective ASD treatment for an individual, this research provides evidence that brain imaging is an important intervention tool.
Currently, functional MRI, the type of brain scan used in this study, is not a standard part of ASD treatment, as there is not enough evidence linking the scan to effective treatments. The Autism and Neurodevelopmental Disorders Institute at GW aims to make significant contributions toward the establishment of evidence-based therapies for ASD.
“This kind of imaging can help us answer the question, ‘On day one of treatment, will this child benefit from a 16-week behavioral intervention?’” Dr. Pelphrey said. “Answering that question will help parents save time and money on diagnosis and treatments.”
Following the study, Dr. Pelphrey and his colleagues will test their findings at the next level: studying a larger pool of people with autism and other neurological disorders in collaboration with Children’s National Medical Center to see if the scan can successfully distinguish ASD from other disorders and track treatment progress.
The authors emphasized that this research is still in its early phase, pointing out that doctors’ offices and most hospitals do not have the specialized imaging equipment necessary to carry out the brain scans used by the team involved in this study.
"To really help patients we need to develop inexpensive, easy-to-use techniques that can be applied in any group, including infants and individuals with severe behavioral problems," said Dr. Björnsdotter. "This study is a first step toward that goal."
While this method currently only works for boys with autism, the researchers are leading a large-scale, nationwide study of girls with autism to identify equivalent techniques that will work for them. The group expects to have the initial results from that study later this year.
Comments